Virtus Fund Advisers’s Amedisys AMED Stock Holding History

Virtus Fund Advisers’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-2,332	Closed	-$39K	–	1186
2014 Q2	$39K	Buy	+2,332	New	+$33K	﹤0.01%	2028

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JCG

JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus Fund Advisers's AMED Position: Q3 2014 in Review

Virtus Fund Advisers sold out of Amedisys (AMED) in Q3 2014, closing a stake of 2,332 shares — an estimated $39K sold.

Virtus Fund Advisers first reported a position in AMED in Q2 2014 and held it in 1 quarter. The position peaked at $39K in Q2 2014. 125 funds tracked by Wall St. Rank hold AMED as of Q3 2014.

Virtus Fund Advisers reported no remaining Amedisys position as of Q3 2014 after selling out during the quarter.
Virtus Fund Advisers sold 2,332 Amedisys shares in Q3 2014, an estimated $39K.
Virtus Fund Advisers first reported a position in Amedisys in Q2 2014 and held it in 1 quarter.
Virtus Fund Advisers's Amedisys position peaked at $39K in Q2 2014.
125 funds tracked by Wall St. Rank held Amedisys as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.